15-day Paxlovid regimen safe but adds no clear long-COVID benefit, trial finds

Paxlovid, effective in preventing severe COVID-19, didn’t appear to help long-COVID patients in this single-center study. But further research may show benefits with different doses or for people with specific symptoms.